# The Effect of a Psychosomatic Symptom Intervention Program on the Primary Treatment of Differentiated Thyroid Cancer

> **NCT06422702** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Harbin Medical University** · enrollment: 84 (estimated)

## Conditions studied

- Pathologically Confirmed Differentiated Thyroid Carcinoma
- All Patients Are in the Initial Treatment Phase
- Normal Cognitive and Communicative Abilities, Capable of Reading and Understanding Questionnaires in Chinese
- Ability to Use a Smartphone
- Voluntary Participation in the Study and Signed Informed Consent

## Interventions

- **OTHER:** Psychosomatic Symptoms Intervention
- **OTHER:** Extended supportive care

## Key facts

- **NCT ID:** NCT06422702
- **Lead sponsor:** Harbin Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-08-01
- **Primary completion:** 2024-01-22
- **Final completion:** 2025-04-22
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2025-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06422702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06422702, "The Effect of a Psychosomatic Symptom Intervention Program on the Primary Treatment of Differentiated Thyroid Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06422702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*